Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19

Stock Information for Forward Pharma A/S

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Forward Pharma A/S

Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital Market
Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review
Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021
Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020
Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2019
Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.